logo
Plus   Neg
Share
Email

Theraclion: FDA Accepts To Review Submission For Approval Of Echopulse Trial

Theraclion, a French company specialized in leading-edge medical devices for echotherapy, Wednesday said it has filed a Pre-Submission for discussion with the Food and Drug Administration regarding the regulatory pathway and clinical data requirements for the Echopulse System.

Theraclion intends to conduct a prospective, randomized, multi-center pivotal study of the Echopulse to further evaluate the device for ablation of breast fibroadenoma.

The study will evaluate changes in fibroadenoma volume and symptoms as well as patient satisfaction.

The proposed pivotal study follows two prior investigations, including a European multi-center study in 42 women with 51 breast fibroadenomas. This study demonstrated an average decrease in fibroadenoma volume of 72.5 percent at the 12-month follow-up, with minimal pain and adverse events related to the treatment.

A pilot study is also ongoing at the University of Virginia, Charlottesville, USA, to further evaluate the Echopulse for treatment of breast fibroadenomas.

The data from both studies, together with the proposed pivotal study, will support the company's premarket submission.

The company expects a meeting with the FDA in the third quarter of 2015 to discuss the final design of the clinical study.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT